Departments and Services | For Patients | Research & Trials | Education | Find a Doctor

Division of Infectious Disease
Division of Infections Disease
Fellowship Program
Clinical Programs
Penn CDC Prevention Epicenters Program
Clinical Trials
Botswana-UPenn Partnership
Adjunct Faculty
Administrative Contacts
Outpatient Clinics


faculty photo

Jay R. Kostman, M.D.

Clinical Professor of Medicine
Health System Clinician, University of Pennsylvania Health System
Attending Physician , Penn Presbyterian Medical Center
Co-Director of HIV/HCV Scientific Working Group, Penn Center for AIDs Research (CFAR)
Associate Director, Viral Hepatitis Center Perelman School of Medicine
Department: Medicine

Contact information
3910 Powelton Avenue
Philadelphia, PA 19104
Office: 215-662-8693
Fax: 215-243-4658
B.A. (Chemistry)
Cornell University, 1980.
Yale University, 1984.
Post-Graduate Training
Resident in Medicine, Temple University Hospital, Philadelphia, PA, 1984-1987.
Chief Resident in Medicine, Temple University Hospital, Philadelphia, PA , 1987-1988.
Fellow in Infectious Diseases, Temple University Hospital, Philadelphia, PA , 1988-1991.
American Board of Internal Medicine, 1987.
Subspecialty of Infectious Diseases, 2008.
Permanent link
> Perelman School of Medicine   > Faculty   > Details

Selected Publications

Patro SC, Pal S, Bi Y, Lynn K, Mounzer KC, Kostman JR, Davuluri RV, Montaner LJ: Shift in Monocyte Apoptosis with Increasing Viral Load and Change in Apoptosis-related ISG/Bcl2-family Gene Expression in Chronic HIV-1 Infected Subjects. Journal of Virology Oct 2014.

Byrne DD, Newcomb CW, Carbonari DM, Nezamzadeh MS, Leidl KBF, Herlim M, Yang Yu-Xiao, Hennessy S, Kostman JR, Leonard MB, Localio AR, Lo Re V: Risk of hip fracture associated with untreated and treated chronic hepatitis B virus infection. Journal of Hepatology 61(2): 210-8, Aug 2014.

Kozak I, Vaidya V, Van Natta ML, Pak JW, May KP, Thorne JE: The prevalence and incidence of epiretinal membranes in eyes with inactive extramacular CMV retinitis. Investigative Ophthalmology & Visual Science 55(7): 4304-12, Jul 2014.

Nordell AD, McKenna M, Borges ÁH, Duprez D, Neuhaus J, Neaton JD: Severity of cardiovascular disease outcomes among patients with HIV is related to markers of inflammation and coagulation. Journal of the American Heart Association 3(3): e000844, Jun 2014.

Byrne DD, Newcomb CW, Carbonari DM, Nezamzadeh MS, Leidl KBF, Herlim M, Yang Y-X, Hennessy S, Kostman JR, Leonard MB, Localio R, Lo Re V: Prevalence of diagnosed chronic hepatitis B infection among U.S. Medicaid enrollees, 2000-2007. Annals of Epidemiology 24(6): 418-23, Jun 2014.

Hafkin JS, Osborn MK, Localio AR, Amorosa VK, Kostman JR, Stern JJ, De La Torre P, Mounzer K, Frank I, Gross R, Chang K-M, Lo Re V: Incidence and risk factors for incomplete HBV DNA suppression in HIV/HBV-co-infected patients initiating tenofovir-based therapy. Journal of Viral Hepatitis 21(4): 288-96, Apr 2014.

Lo Re V, Kallan MJ, Tate JP, Localio AR, Lim JK, Goetz MB, Klein MB, Rimland D, Rodriguez-Barradas MC, Butt AA, Gibert CL, Brown ST, Park L, Dubrow R, Reddy KR, Kostman JR, Strom BL, Justice AC: Hepatic decompensation in antiretroviral-treated patients co-infected with HIV and hepatitis C virus compared with hepatitis C virus-monoinfected patients: a cohort study. Annals of Internal Medicine 160(6): 369-79, Mar 2014.

Tomescu C, Liu Q, Ross BN, Yin X, Lynn K, Mounzer KC, Kostman JR, Montaner LJ: A correlate of HIV-1 control consisting of both innate and adaptive immune parameters best predicts viral load by multivariable analysis in HIV-1 infected viremic controllers and chronically-infected non-controllers. PloS one 9(7): e103209, 2014.

Borges AH, O'Connor JL, Phillips AN, Baker JV, Vjecha MJ, Losso MH, Klinker H, Lopardo G, Williams I, Lundgren JD: Factors associated with D-dimer levels in HIV-infected individuals. PloS one 9(3): e90978, 2014.

Azzoni L, Foulkes AS, Papasavvas E, Mexas AM, Lynn KM, Mounzer K, Tebas P, Jacobson JM, Frank I, O'Doherty U, Kostman J, Montaner LJ: Improved treatment for primary HIV infection by interferon-alfa therapy? Does HCV treatment in HIV/HCV coinfected patients help us to test this hypothesis? Reply to zur Wiesch and van Lunzen. J Inf Dis 208(2): 363, Jul 2013.

back to top
Last updated: 01/20/2015
The Trustees of the University of Pennsylvania